The history of Bottu is primarily one of dedicated employees who share a corporate culture with strong values. Thanks to their efforts, they were able to build a pharmaceutical company whose professionalism, dynamism and ambition have never been denied over the years.
Milestones
1964
Introduction of Doliprane in the Moroccan market
2001
Industrial investments : Upgrading of production equipment and increase of its capacity
2002
Acquisition of Doliprane brand in Morocco
2007
Significant restructuring and corporate reorganization
2009
-Construction of a 2nd manufacturing site
-Starting Export activity
2010
ISO 9001 version 2008 Certification
2011
Construction of a 3d manufacturing site
2016
-ISO 14001 V 2004 - OHSAS 18001 V 2007 Certifications
-Creation of Bottu International
2017
-ISO 9001/14001 V 2015 Certifications
-Acquisition of Sophanord Group
2018
GCC Certification - Gulf Cooperation Council
2020
-AEO (Authorized Economic Operator) Safety-Security
-ISO 45001 V 2018 Certification
2022
Inauguration of new Head Office and factory extension
2023
-ISO 13485 V 2016 Certification
-Acquisition of BioXpert with a major equity stake majoritaire au capital
2024
-Commitment to a voluntary CSR initiative
-Renewal of the AEO SS “Safety and Security“ certificate